Regulation of δ opioid receptors by Δ9-tetrahydrocannabinol in NG108- 15 hybrid cells

Life Sciences

Volumn 63, Issue 14, 1998, Pages

  Di Toro, Rosanna ^a   Campana, Gabriele ^a   Sciarretta, Vittorio ^a   Murari, Giovanna ^a   Spampinato, Santi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

9 tetrahydrocannabinol; opioid receptor; G protein receptor desensitization; Receptor down regulation

Indexed keywords

CANNABINOID RECEPTOR; CYCLIC AMP; DELTA OPIATE RECEPTOR; DRONABINOL; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MESSENGER RNA; PERTUSSIS TOXIN; RIMONABANT;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GLIOMA CELL; INCUBATION TIME; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RNA ANALYSIS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, LEUCINE; FORSKOLIN; GLIOMA; MICE; NEUROBLASTOMA; PIPERIDINES; PYRAZOLES; RATS; RECEPTORS, OPIOID, DELTA; RNA, MESSENGER; TETRAHYDROCANNABINOL; TUMOR CELLS, CULTURED;

EID: 0344549150     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00390-7     Document Type: Article

References (27)

1. 1. W.L. DEWEY, Pharmacol. Rev. 38 151-178 (1986).
2. 2. C.C. FELDER, K.E. JOYCE, E.M. BRILEY, J. MANSOURI, K. MACKIE, O. BLOND, Y. LAY, A.L. MA and R.L. MITCHELL, Mol. Pharmacol. 48 443-450 (1995).
3. 3. L.A. MATSUDA, S.J. LOLAIT, M.J. BROWNSTEIN, A.C. YOUNG and T. I. BONNER, Nature 346 561-564 (1990).
4. 4. S. MUNRO, K.L. THOMAS and M. ABU-SHAAR, Nature 365 61-65 (1993).
5. 5. P.B. SMITH, S.P. WELCH and B.R. MARTIN, J. Pharmacol. Exp. Ther. 268 1381-1387 (1994).
6. 6. I. RECHE, J.A. FUENTES and M. RUIZ-GAYO, Eur. J. Pharmacol. 318 11-16 (1996).
7. 7. S.N. THORAT and H.N. BHARGAVA, Eur. J. Pharmacol. 260 5-13 (1994).
8. 8. H.N. BHARGAVA, Eur. J. Pharmacol. 36 259-262 (1976).
9. 9. J. CORCHERO, M.A. AVILA, J.A. FUENTES and J. MANZANARES, Life Sci. 61 PL39-43 (1997).
10. 10. P. MAILLEUX and J.-J. VANDERHAEGHEN, Eur. J. Pharmacol. 261 R1-3 (1994).
11. 11. A.C. HOWLETT, J.M. QUALY and L.L. KHACHATRIAN, Mol. Pharmacol. 29 307-313 (1986).
12. 12. X. PAN, S.R. IKEDA and D.L. LEWIS, Mol. Pharmacol. 49 707-714 (1996).
13. 13. M. SATOH and M. MINAMI, Pharmac. Ther. 68 343-364 (1995).
14. 14. T.T. CHUANG, L. IACOVELLI, M. SALLESE and A. DE BLASI, Trends Pharmacol. Sci. 17 416-421 (1996).
15. 15. P. J.-J. VAYSSE, E.L. GARDNER and R.S. ZUKIN, J. Pharmacol. Exp. Ther. 241 534-539 (1987).
16. 16. M. RINALDI-CARMONA, F. BARTH, M. HEAULME, D. SHIRE, B. CALANDRA, C. CONGY, S. MARTINEZ, J. MARUANI, G. NEHAT, D. CAPUT, P. FENARA, P. SOUBRIE', J.C. BRELIERE and G. LE FUR, FEBS Lett. 350 240-244 (1994).
17. 17. P.Y. LAW, D.S. HOM and H.H. LOH, Mol. Pharmacol. 22 1-4 (1982).
18. 18. O.H. LOWRY, N.J. ROSEBROUGH, A.L. FARR and R.J. RANDALL, J. Biol. Chem. 193 265-275 (1951).
19. 19.X. SU, T.F. SULLIVAN, S. BURSZTAJN and S. A. BERMAN, Biotechniques 17 734-736 (1994).
20. 20. P.J. MUNSON and D. RODBARD, Anal. Biochem. 107 220-239 (1980).
21. 21. L. L. WERLING, P.N. MCMAHON and B.M. COX, Proc. Natl. Acad. Sci. USA 86 6393-6397 (1989).
22. 22. P.S. PUTTFARCKEN, L.L. WERLING and B.M. COX, Mol. Pharmacol. 33 520-527 (1998).
23. 23. B. BUZAS, J. ROSENBERGER and B.M. COX, NeuroReport 7 1505-1508 (1996).
24. 24. G. PEI, B.L. KIEFFER, R.J. LEIFKOWITZ and J.F. NEIL, Mol. Pharmacol. 48 173-177 (1995).
25. 25. S. GUCKER and J.M. BIDLACK, Mol. Pharmacol. 42 656-665 (1992).
26. 26. E.J. NESTLER, Neuron 16 897-900 (1996).
27. 27. M. RINALDI-CARMONA, B. CALANDRA, D. SHIRE, M. BOUABOULA, D. OUSTRIC, F. BARTH, P. CASELLAS, P. FERRARA and G. LE FUR, J. Pharmacol. Exp. Ther. 278 871-878 (1996).